Annotation Detail for CSRNP2
Basic Information
Top
| Gene Symbol: | CSRNP2 ( C12orf2,C12orf22,FAM130A1,FLJ25576,TAIP-12 ) |
|---|
| Gene Full Name: | cysteine-serine-rich nuclear protein 2 |
|---|
| Band: | 12q13.12 |
|---|
| Quick Links | Entrez ID:81566; OMIM: NA; Uniprot ID:CSRN2_HUMAN; ENSEMBL ID: ENSG00000110925; HGNC ID: 16006 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CSRNP2 mRNA | increases expression | 20106945
|
| D002117 |
Calcitriol |
Calcitriol results in decreased expression of CSRNP2 mRNA | decreases expression | 16002434
|
| D008942 |
Mitoxantrone |
CSRNP2 mRNA affects the susceptibility to Mitoxantrone | affects response to substance | 16044152
|
| C025299 |
polyphenols |
polyphenols results in decreased expression of CSRNP2 mRNA | decreases expression | 16293270
|
| D011374 |
Progesterone |
Progesterone results in increased expression of CSRNP2 mRNA | increases expression | 18037150
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of CSRNP2 mRNA | decreases expression | 18175754
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.86 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.68 | 15380490 15665606 15845082 |
| MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.35 | 11237771 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.35 | 16175315 15562024 17614352 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.69 | 11237771 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.73 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
| MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.71 | 16293270 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.91 | 17187935 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
4.51 | 19370779 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.51 | 15131321 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
10.61 | 15138306 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
10.61 | 17692515 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
4.07 | 16134523 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.18 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12168785 12639820 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
| MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.36 | 16019553 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.82 | 15869954 |
| MESH:D007249 |
Inflammation |
|
polyphenols |
5.91 | 16366677 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
5.91 | 15869954 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.50 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.00 | 12371664 |
| MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.90 | 18172266 |
| MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.84 | 16698588 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
3.05 | 17203775 11408345 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
| MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
3.55 | 16640825 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 18481113 19348381 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.60 | 16525653 17393432 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
| MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.24 | 15572423 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.36 | 16644109 18247401 16289102 15754350 12479363 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.36 | 18760546 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.94 | 18045962 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.74 | 16503802 15862959 |
| MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.77 | 17997062 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |
Related Pathway Information